Overview

A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia

Status:
Terminated

Trial end date:
2011-01-01

Target enrollment:

Participant gender:

Summary

This is an open label randomized controlled phase II study of AS1411 combined with Cytarabine in the treatment of patients with primary refractory or relapsed acute myeloid leukemia.

Phase:

Phase 2

Details

Lead Sponsor:

Antisoma Research

Treatments:

Cytarabine